FDA Logo links to FDA home page
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

FDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status

horizonal rule

Dockets Management
Dockets Entered On February 8, 2006
Table of Contents
Docket # Title
1976N-0052G OTC general comments & combinations
1990S-0308 Generic Drug Speeches & Policy and Procedure Guides
1998P-0151 Introduction Of Downed Cattle Into The Food Supply
1998P-0724 Prohibition of Cochineal Extract and Carmine Color Additives
2001P-0075 Switch Status of Emergency Contraceptives from Rx to OTC
2002N-0273 Animal Proteins Prohibited in Ruminant Feed
2004N-0556 Obstetrical and Gynecological Devices; Designation of Special Control for Condom and Condom with Spermicidal Lubricant
2004P-0183 Nutrient Content Claim: Expand Lean Definition
2005D-0344 Class II Special Controls Guidance Document: Tinnitus Masker Devices
2005D-0481 Guidance for Industry, Lead in Candy Likely To Be Consumed Frequently by Small Children: Recommended Maximum Level and Enforcement Policy, Availability; and draft supporting document, Supporting Do
2005D-0490 Guidance for Industry: Questions and Answers Regarding Food Allergens, including the Food Allergen Labeling and Consumer Protection Act of 2004 (Edition 2)
2005N-0285 Current Good Manufacturing Practice Regulation and Investigational New Drugs
2005N-0354 Consumer-Directed Promotion of Regulated Medical Products; Part 15 Public Hearing
2005N-0374 Use of Ozone-Depleting Substance: Essential-Use Determination of Over the Counter Epinephrine Metered-Dose Inhalers
2005P-0325 Request Commissioner of Food and Drugs to amend its regulations related to sugar and alternative sweeteners
2005P-0411 Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
2005P-0498 Criteria of generic version of Wellbutrin XL (bupropion hydrochloride extended-release tablets)
1976N-0052G OTC general comments & combinations
EC 3 Ms. Barbara Houston Vol #: 35
EC 4 Mr. Christopher Jones Vol #: 35
EC 5 Mrs. Donna Watson Vol #: 35
1990S-0308 Generic Drug Speeches & Policy and Procedure Guides
RPT 763 Statistical Report - Month of January 2006 Vol #: 53
1998P-0151 Introduction Of Downed Cattle Into The Food Supply
C 7515 C. Huson Vol #: 319
C 7516 Namazzi Vol #: 319
C 7517 K. Parent Vol #: 319
1998P-0724 Prohibition of Cochineal Extract and Carmine Color Additives
EC 5 Mrs. KARLA PETRICK Vol #: 1
EC 6 Ms. Eileen Smith Vol #: 1
EC 7 Mr. Don Riley Vol #: 1
EC 8 Mr. Victor Somers Vol #: 1
EC 9 Mrs. Jennifer Yarbrough Vol #: 1
EC 10 Mrs. SUZANNE BONNER Vol #: 1
2001P-0075 Switch Status of Emergency Contraceptives from Rx to OTC
C 2096 J. Cunningham Vol #: 300
2002N-0273 Animal Proteins Prohibited in Ruminant Feed
C 531 Form Letter Vol #: 46
2004N-0556 Obstetrical and Gynecological Devices; Designation of Special Control for Condom and Condom with Spermicidal Lubricant
EC 24 Lifelong AIDS Alliance Vol #: 1
EC 25 Ms. katherine hogan Vol #: 1
2004P-0183 Nutrient Content Claim: Expand Lean Definition
EC 1 Mr. Steven Steinborn Vol #: 4
2005D-0344 Class II Special Controls Guidance Document: Tinnitus Masker Devices
EC 1 Neuromonics Pty Ltd Vol #: 1
2005D-0481 Guidance for Industry, Lead in Candy Likely To Be Consumed Frequently by Small Children: Recommended Maximum Level and Enforcement Policy, Availability; and draft supporting document, Supporting Do
EC 3 Sun Chemical Corporation Vol #: 1
2005D-0490 Guidance for Industry: Questions and Answers Regarding Food Allergens, including the Food Allergen Labeling and Consumer Protection Act of 2004 (Edition 2)
EC 7 Ft Worth GIG Gluten Intolerant Group Vol #: 1
EC 8 Ms. Barbara Carey, R.N. Vol #: 1
EC 9 Ms. Melissa Barman Vol #: 1
EC 10 Alamo Celiac Vol #: 1
2005N-0285 Current Good Manufacturing Practice Regulation and Investigational New Drugs
EC 1 Ms. Beth Incao Vol #: 1
2005N-0354 Consumer-Directed Promotion of Regulated Medical Products; Part 15 Public Hearing
EC 434 Dr. Marc Harmon Vol #: 10
2005N-0374 Use of Ozone-Depleting Substance: Essential-Use Determination of Over the Counter Epinephrine Metered-Dose Inhalers
C 7 B. Greene Vol #: 1
2005P-0325 Request Commissioner of Food and Drugs to amend its regulations related to sugar and alternative sweeteners
SUP 1 Sugar Association Vol #: 2
2005P-0411 Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
C 612 K. Albert Vol #: 12
C 613 E. Caddick Vol #: 12
C 614 J. Nielsen, MD Vol #: 12
C 615 eligible Vol #: 12
C 616 B. Story Vol #: 12
C 617 A. Martone Vol #: 12
C 618 D. Kiernan Vol #: 12
C 619 J. Delafield Vol #: 12
C 620 D. Schlemeier Vol #: 12
C 621 S. Hipple Vol #: 12
C 622 C. Ehridge Vol #: 12
C 623 S. Edwards Vol #: 12
C 624 T. Talbert Vol #: 12
C 625 K. Riva Vol #: 12
C 626 C. Toman Vol #: 12
C 627 J. Smith Vol #: 12
C 628 T. Ayorte Vol #: 12
C 629 J. Delafield Vol #: 12
C 630 L. Butler Vol #: 12
C 631 A. Sutherland Vol #: 12
C 632 A. Shoemaker Vol #: 12
C 633 E. Praisan Vol #: 12
C 634 J. Thrasher Vol #: 12
C 635 R. Butler Vol #: 12
C 636 S. Berkemeier Vol #: 12
C 637 A. Brians Vol #: 12
C 638 J. Zeillmann Vol #: 12
C 639 T. Sullivan Vol #: 12
C 640 K. Phillips Vol #: 12
EC 1081 Babcock Vol #: 7
2005P-0498 Criteria of generic version of Wellbutrin XL (bupropion hydrochloride extended-release tablets)
EC 4 Dr. Nadir Nugasha Vol #: 1

Page created on February 23, 2006 RSC

horizonal rule

Dockets Home| Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | A-Z Index | Contact FDA | Privacy | Accessibility

FDA/Dockets Management